Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background

Lupus

Volumn 19, Issue 7, 2010, Pages 815-829

  Rashtak, S ^a,b   Marietta, E ^b   Cheng, S ^b   Camilleri, M ^b   Pittelkow, M ^b   David, C ^b   Grande, J ^a   Murray, J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Autoimmune; Glomerulonephritis; HLA DQ2; Lupus; MHC class II; Mice; Transgenic

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C1Q; DOUBLE STRANDED DNA; HLA DQ2 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLISTER; CAPILLARY WALL; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATURIA; HISTOPATHOLOGY; HYPERKERATOSIS; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; LUPUS LIKE SYNDROME; LYMPHOCYTIC INFILTRATION; MESANGIUM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; TRANSGENIC MOUSE; URINALYSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HLA-DQ ANTIGENS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, ELECTRON;

EID: 77952925193     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309360546     Document Type: Article

References (62)

1. Martin-Villa JM, Martinez-Laso J., Moreno-Pelayo MA, et al. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production. Ann Rheum Dis 1998 ; 57: 214-219.
2. Vargas-Alarcon G., Salgado N., Granados J., et al. Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility. Hum Immunol 2001 ; 62: 814-820.
3. Tjernstrom F., Hellmer G., Nived O., Truedsson L., Sturfelt G. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus 1999 ; 8: 103-108.
4. Lambert AP, Gillespie KM, Thomson G., et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004 ; 89: 4037-4043.
5. Segni M., Pani MA, Pasquino AM, Badenhoop K. Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. J Clin Endocrinol Metab 2002 ; 87: 3779-3782.
6. Chen QY, Nadell D., Zhang XY, et al. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 2000 ; 85: 1545-1549.
7. Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 2001 ; 11: 31-35.
8. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993 ; 105: 910-922.
9. Hall MA, Lanchbury JS, Bolsover WJ, Welsh KI, Ciclitira PJ HLA association with dermatitis herpetiformis is accounted for by a cis or trans associated DQ heterodimer. Gut 1991 ; 32: 487-490.
10. Czaja AJ, Santrach PJ, Moore SB HLA-DQ associations in type 1 autoimmune hepatitis. Mayo Clin Proc 1995 ; 70: 1154-1160.
11. Sanjeevi CB HLA-DQ6-mediated protection in IDDM. Hum Immunol 2000 ; 61: 148-153.
12. Poussin MA, Goluszko E., David CS, Franco JU, Christadoss P. HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production. J Autoimmun 2001 ; 17: 175-180.
13. Kouskoff V., Fehling HJ, Lemeur M., Benoist C., Mathis D. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J Immunol Methods 1993 ; 166: 287-291.
14. Madsen L., Labrecque N., Engberg J., et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci USA 1999 ; 96: 10338-10343.
15. Cheng S., Smart M., Hanson J., David CS Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes. J Autoimmun 2003 ; 21: 195-199.
16. Bradley DS, Nabozny GH, Cheng S., et al. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest 1997 ; 100: 2227-2234.
17. Bayani J., Squire J. Multi-color FISH techniques. Curr Protoc Cell Biol 2004 ; Chapter 22: Unit 22 5.
18. Wang B., Yamamoto Y., El-Badri NS, Good RA Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc Natl Acad Sci USA 1999 ; 96: 3012-3016.
19. McDowell EM, Trump BF Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 1976 ; 100: 405-414.
20. Spurr AR A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 1969 ; 26: 31-43.
21. Nath KA, Grande JP, Croatt AJ, Likely S., Hebbel RP, Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int 1998 ; 53: 100-111.
22. Hvala A., Kobenter T., Ferluga D. Fingerprint and other organised deposits in lupus nephritis. Wien Klin Wochenschr 2000 ; 112: 711-715.
23. Hamaya K., Doi K. Fingerprint-like straight crystalloid microfilaments in lobular glomerulonephritis. Acta Pathol Jpn 1985 ; 35: 767-773.
24. Kelly JA, Moser KL, Harley JB The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 2002 ; 3 (Suppl 1). S71 - S85.
25. Lindqvist AK, Alarcon-Riquelme ME The genetics of systemic lupus erythematosus. Scand J Immunol 1999 ; 50: 562-571.
26. Vyse TJ, Kotzin BL Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 1998 ; 16: 261-292.
27. Bagavant H., Fu SM New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells. Curr Opin Rheumatol 2005 ; 17: 523-528.
28. Bagavant H., Deshmukh US, Gaskin F., Fu SM Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand J Immunol 2004 ; 60: 52-63.
29. Zhu J., Mohan C. SLE 1, 2, 3... genetic dissection of lupus. Adv Exp Med Biol 2007 ; 601: 85-95.
30. Marchini M., Antonioli R., Lleo A., et al. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol 2003 ; 64: 462-468.
31. Howard PF, Hochberg MC, Bias WB, Arnett FC Jr, McLean RH Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med 1986 ; 81: 187-193.
32. Hashimoto H., Nishimura Y., Dong RP, et al. HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994 ; 23: 191-196.
33. Jonsen A., Bengtsson AA, Sturfelt G., Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res Ther 2004 ; 6: R557 - R562.
34. Gambelunghe G., Gerli R., Bocci EB Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 2005 ; 44: 287-292.
35. Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002 ; 71: 543-553.
36. Uribe AG, McGwin G. Jr, Reveille JD, Alarcon GS What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? Autoimmun Rev 2004 ; 3: 321-329.
37. Wakeland EK, Liu K., Graham RR, Behrens TW Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001 ; 15: 397-408.
38. Hartung K., Baur MP, Coldewey R., et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 1992 ; 90: 1346-1351.
39. van der Linden MW, van der Slik AR, Zanelli E., et al. Six micro-satellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun 2001 ; 2: 373-380.
40. Rood MJ, van Krugten MV, Zanelli E., et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000 ; 43: 129-134.
41. Alarcon GS, Roseman J., Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998 ; 41: 1173-1180.
42. Mangalam A., Rodriguez M., David C. Role of MHC class II expressing CD4+ T cells in proteolipid protein (91-110)-induced EAE in HLA-DR3 transgenic mice. Eur J Immunol 2006 ; 36: 3356-3370.
43. Paisansinsup T., Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS HLA class II influences the immune response and antibody diversification to Ro60/Sjogren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol 2002 ; 168: 5876-5884.
44. Taneja V., Behrens M., Mangalam A., Griffiths MM, Luthra HS, David CS New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum 2007 ; 56: 69-78.
45. Chen Z., Dudek N., Wijburg O., et al. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice. J Immunol 2002 ; 168: 3050-3056.
46. Chen D., Ueda R., Harding F., et al. Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies. Eur J Immunol 2003 ; 33: 172-182.
47. Shirakawa F., Yamashita U., Suzuki H. Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Immunol 1985 ; 134: 3560-3562. (Pubitemid 15034355)
48. Shirakawa F., Yamashita U., Suzuki H. Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Clin Immunol 1985 ; 5: 396-403. (Pubitemid 16199508)
49. Gardiner KR, Crockard AD, Halliday MI, Rowlands BJ Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease. Gut 1994 ; 35: 511-516.
50. Sano H., Compton LJ, Shiomi N., Steinberg AD, Jackson RA, Sasaki T. Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus. J Clin Invest 1985 ; 76: 1314-1322.
51. Sontheimer RD, Gilliam JN A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol 1979 ; 72: 29-32.
52. Sontheimer RD Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol 1996 ; 63: 583-594.
53. Tojo A., Kimura K., Hirata Y., Matsuoka H., Sugimoto T. Silent lupus nephritis with fingerprint deposits. Intern Med 1993 ; 32: 323-326.
54. Zhang FC, Zhou B., Dong Y. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis.] Zhonghua Yi Xue Za Zhi 2005 ; 85: 955-959.
55. Sinniah R., Feng PH Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Clin Nephrol 1976 ; 6: 340-351.
56. Gubbels MR, Jorgensen TN, Metzger TE, et al. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. J Immunol 2005 ; 175: 6190-6196.
57. Dumont F., Monier JC Sex-dependent systemic lupus erythematosus-like syndrome in (NZB × SJL)F1 mice. Clin Immunol Immunopathol 1983 ; 29: 306-317.
58. Hudgins CC, Steinberg RT, Klinman DM, Reeves MJ, Steinberg AD Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol 1985 ; 134: 3849-3854.
59. Cohen MG, Pollard KM, Schrieber L. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice. Clin Exp Immunol 1988 ; 72: 50-54.
60. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978 ; 148: 1198-1215.
61. Xie C., Zhou XJ, Liu X., Mohan C. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum 2003 ; 48: 1080-1092.
62. Singh RR SLE: translating lessons from model systems to human disease. Trends Immunol 2005 ; 26: 572-579.